Company / Revenue
MEDICINOVA INC Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$409.7K
FY2025
5-year range
$409.7K / $4.0M
FY2021-FY2025
Trend
-59.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $409,657 over the past 2 years.
Based on SEC 10-K filings.
$409,657 in FY2025.
Declined from $1M to $409,657 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue decreased 59.0% year-over-year.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $409.7K | -59.0% |
| FY2024 | $1.0M | +0.0% |
| FY2023 | $1.0M | - |
| FY2022 | - | - |
| FY2021 | $4.0M | - |
| FY2014 | - | - |
| FY2013 | $3.0K | -98.4% |
| FY2012 | $191.0K | -87.7% |
| FY2011 | $1.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026